Switch to:
GuruFocus has detected 2 Warning Signs with ChemoCentryx Inc $CCXI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
ChemoCentryx Inc (NAS:CCXI)
EV-to-EBITDA
-6.99 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, ChemoCentryx Inc's enterprise value is $213.95 Mil. ChemoCentryx Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-30.59 Mil. Therefore, ChemoCentryx Inc's EV/EBITDA ratio for today is -6.99.

CCXI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -86   Max: -0.1
Current: -6.99

-86
-0.1

During the past 8 years, the highest EV/EBITDA Ratio of ChemoCentryx Inc was -0.10. The lowest was -86.00. And the median was -5.25.

CCXI's EV-to-EBITDA is ranked lower than
99.99% of the 466 Companies
in the Global Biotechnology industry.

( Industry Median: 17.12 vs. CCXI: -6.99 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, ChemoCentryx Inc's stock price is $6.90. ChemoCentryx Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.65. Therefore, ChemoCentryx Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

ChemoCentryx Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=213.953/-30.587
=-6.99

ChemoCentryx Inc's current Enterprise Value is $213.95 Mil.
ChemoCentryx Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -10.057 (Jun. 2016 ) + -7.244 (Sep. 2016 ) + -7.071 (Dec. 2016 ) + -6.215 (Mar. 2017 ) = $-30.59 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

ChemoCentryx Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=6.90/-0.65
=

ChemoCentryx Inc's share price for today is $6.90.
ChemoCentryx Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.22 (Jun. 2016 ) + -0.15 (Sep. 2016 ) + -0.16 (Dec. 2016 ) + -0.12 (Mar. 2017 ) = $-0.65.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

ChemoCentryx Inc Annual Data

Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda 0.000.000.000.000.00-7.68-3.03-4.82-6.12-6.00

ChemoCentryx Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -4.82-5.41-6.23-4.05-6.12-0.92-1.84-3.82-6.00-7.59
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK